Biotechnology Market Research Reports & Industry Analysis

In industries from agriculture to environmental science, biotechnology plays an important role in improving industry standards, services, and developing new products. Biotechnology involves the spectrum of life science-based research companies working on transformative technologies for a wide range of industries.

While agriculture, material science and environmental science are major areas of research, the largest impact is made in the field medicine. As a large player in the research and development of pharmaceuticals, the role of biotechnology in the healthcare field is undeniable. From genetical analysis and manipulation to the formation of new drugs, many biotech firms are transforming into pharmaceutical and biopharmaceutical leaders.

This research category includes various comprehensive reports on research methods, biotech companies, tools, technologies, and equipment commonly used in the biotech industry. You will also find business reports covering funding, product pipelines, mergers and acquisitions, and strategies for development. The “green” and “white” biotech sectors are also covered in the reports herein.

...Show More ...Show Less


Biotechnology Industry Research & Market Reports

  • Global Liquid Biopsy Market Forecast 2020-2028

    ... market growth are growth in precision medicine, rising government initiatives, the growing pervasiveness of cancer in the older population, increasing potential of liquid biopsies, and technological advancements. MARKET INSIGHTS Due to rapid changes in consumer ... Read More

  • Artificial Intelligence (AI) in Cancer

    ... health management of cancer - Information on types of complex algorithms developed for cancer - Discussion of major issues related to the utilization of AI for diagnosis and treatment of cancer - Analysis of the ... Read More

  • Anti-CD33 Antibody -Pipeline Insight, 2020

    ... is provided, which includes the topic overview and Anti-CD33 Antibody mechanism of action. The assessment part of the report embraces, in-depth Anti-CD33 Antibody commercial assessment and clinical assessment of the pipeline products under development. In ... Read More

  • Fatty Acid Amide Hydrolase (FAAH) Inhibitor -Pipeline Insight, 2020

    ... Fatty Acid Amide Hydrolase (FAAH) Inhibitor pipeline landscape is provided, which includes the topic overview and Fatty Acid Amide Hydrolase (FAAH) Inhibitor mechanism of action. The assessment part of the report embraces, in-depth Fatty Acid ... Read More

  • Anti-CD80 Antibody -Pipeline Insight, 2020

    ... is provided, which includes the topic overview and Anti-CD80 Antibody mechanism of action. The assessment part of the report embraces, in-depth Anti-CD80 Antibody commercial assessment and clinical assessment of the pipeline products under development. In ... Read More

  • Anti-Mucin 1 (MUC1) Antibody -Pipeline Insight, 2020

    ... (MUC1) Antibody pipeline landscape is provided, which includes the topic overview and Anti-Mucin 1 (MUC1) Antibody mechanism of action. The assessment part of the report embraces, in-depth Anti-Mucin 1 (MUC1) Antibody commercial assessment and clinical ... Read More

  • Anti-CD28 Antibody -Pipeline Insight, 2020

    ... is provided, which includes the topic overview and Anti-CD28 Antibody mechanism of action. The assessment part of the report embraces, in-depth Anti-CD28 Antibody commercial assessment and clinical assessment of the pipeline products under development. In ... Read More

  • Anti-CD52 Antibody -Pipeline Insight, 2020

    ... is provided, which includes the topic overview and Anti-CD52 Antibody mechanism of action. The assessment part of the report embraces, in-depth Anti-CD52 Antibody commercial assessment and clinical assessment of the pipeline products under development. In ... Read More

  • Anti-CD40 Antibody -Pipeline Insight, 2020

    ... is provided, which includes the topic overview and Anti-CD40 Antibody mechanism of action. The assessment part of the report embraces, in-depth Anti-CD40 Antibody commercial assessment and clinical assessment of the pipeline products under development. In ... Read More

  • Anti-CD3 Antibody -Pipeline Insight, 2020

    ... is provided, which includes the topic overview and Anti-CD3 Antibody mechanism of action. The assessment part of the report embraces, in-depth Anti-CD3 Antibody commercial assessment and clinical assessment of the pipeline products under development. In ... Read More

  • Anti-CD152 Antibody -Pipeline Insight, 2020

    ... is provided, which includes the topic overview and Anti-CD152 Antibody mechanism of action. The assessment part of the report embraces, in-depth Anti-CD152 Antibody commercial assessment and clinical assessment of the pipeline products under development. In ... Read More

  • Anti-CD37 Antibody -Pipeline Insight, 2020

    ... is provided, which includes the topic overview and Anti-CD37 Antibody mechanism of action. The assessment part of the report embraces, in-depth Anti-CD37 Antibody commercial assessment and clinical assessment of the pipeline products under development. In ... Read More

  • Anti-CD274 (PD-L1) Antibody -Pipeline Insight, 2020

    ... pipeline landscape is provided, which includes the topic overview and Anti-CD274 (PD-L1) Antibody mechanism of action. The assessment part of the report embraces, in-depth Anti-CD274 (PD-L1) Antibody commercial assessment and clinical assessment of the pipeline ... Read More

  • Hepatitis C Virus (HCV) Protease Inhibitor -Pipeline Insight, 2020

    ... Hepatitis C Virus (HCV) Protease Inhibitor pipeline landscape is provided, which includes the topic overview and Hepatitis C Virus (HCV) Protease Inhibitor mechanism of action. The assessment part of the report embraces, in-depth Hepatitis C ... Read More

  • Anti-CD38 Antibody -Pipeline Insight, 2020

    ... is provided, which includes the topic overview and Anti-CD38 Antibody mechanism of action. The assessment part of the report embraces, in-depth Anti-CD38 Antibody commercial assessment and clinical assessment of the pipeline products under development. In ... Read More

  • Anti-Dickkopf-1 (Dkk-1) Antibody -Pipeline Insight, 2020

    ... pipeline landscape is provided, which includes the topic overview and Anti-Dickkopf-1 (Dkk-1) Antibody mechanism of action. The assessment part of the report embraces, in-depth Anti-Dickkopf-1 (Dkk-1) Antibody commercial assessment and clinical assessment of the pipeline ... Read More

  • Anti-CD19 Antibody -Pipeline Insight, 2020

    ... is provided, which includes the topic overview and Anti-CD19 Antibody mechanism of action. The assessment part of the report embraces, in-depth Anti-CD19 Antibody commercial assessment and clinical assessment of the pipeline products under development. In ... Read More

  • Anti-CD279 (PD-1) Antibody -Pipeline Insight, 2020

    ... pipeline landscape is provided, which includes the topic overview and Anti-CD279 (PD-1) Antibody mechanism of action. The assessment part of the report embraces, in-depth Anti-CD279 (PD-1) Antibody commercial assessment and clinical assessment of the pipeline ... Read More

  • Angiotensin Converting Enzyme (ACE) Inhibitor -Pipeline Insight, 2020

    ... Converting Enzyme (ACE) Inhibitor pipeline landscape is provided, which includes the topic overview and Angiotensin Converting Enzyme (ACE) Inhibitor mechanism of action. The assessment part of the report embraces, in-depth Angiotensin Converting Enzyme (ACE) Inhibitor ... Read More

  • Ubiquitin conjugating enzyme Inhibitor -Pipeline Insight, 2020

    ... enzyme Inhibitor pipeline landscape is provided, which includes the topic overview and Ubiquitin conjugating enzyme Inhibitor mechanism of action. The assessment part of the report embraces, in-depth Ubiquitin conjugating enzyme Inhibitor commercial assessment and clinical ... Read More

  • Anti GM-CSF Antibody -Pipeline Insight, 2020

    ... pipeline landscape is provided, which includes the topic overview and Anti GM-CSF Antibody mechanism of action. The assessment part of the report embraces, in-depth Anti GM-CSF Antibody commercial assessment and clinical assessment of the pipeline ... Read More

  • Impact on Publicly Traded Bio/Pharma Companies - Coronavirus Disease (COVID-19) 2019 Impact Report

    ... future revenue, and market capitalization. Scope This report gives an important expert analysis on how COVID-19 has affected, and will continue to affect, the top 20 Mega Cap Bio/Pharma Companies. Findings are based on the ... Read More

  • Impact of COVID-19 on Pharmaceutical Social Media Influencer Activity

    ... world, with the World Health Organization (WHO) officially declaring the novel coronavirus a pandemic on March 11, 2020. This report analyzes GlobalData’s social media Influencer dashboards to understand Influencer trends since the pandemic began and ... Read More

  • Five Prime Therapeutics Inc (FPRX) - Financial and Strategic SWOT Analysis Review

    ... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More

  • Human Gene Sequencing Markets, Strategies & Trends. Forecasts by Hereditary, Newborn Screening, NIPT, Oncology, Pharmacogenomic, and Direct to Consumer, by Country. With Executive and Consultant Guides. 2020 to 2024

    ... receive genetic testing at birth? Why has Direct to Consumer Testing taken a big jump? What’s holding the industry back? Where are the over 800 locations that have high throughput sequencing devices? Our facts and ... Read More

< prev 1 3 4 5 6 7 8 9 10